Our Vision

Sinclair is a specialty pharma company providing solutions to treat dermatological, oral care and gynecological diseases through advanced surface technology and innovative delivery systems.

Our Strategy

• Goal to deliver sustainable profitability from recurring revenue

• Sinclair focuses on dermatology, and intends to exploit the value of other in-house technologies and assets, notably Decapinol and Delmopinol, OB‑GYN and silver nanotechnology

• Sinclair’s plan is to build European critical mass in the dermatology arena with a view to becoming an in-licensing agent of choice

• With the backing of high-profile new investors, Sinclair seeks to create shareholder value through the addition of product acquisitions and selected M&A targets in order to sweat the assets of its core specialty pharma business

• Reduce complexity and improve profitability by marketing fewer, strategic products